Lemborexant in Delayed Sleep Phase Syndrome

NCT05463861 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Delayed Sleep Phase Syndrome

Interventions

DRUG: Lemborexant
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]